Yi Hu Selected Research

Yi Hu Research Topics

Disease

214	Neoplasms (Cancer) 04/2024 - 01/2003
68	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 02/2024 - 03/2006
39	Neoplasm Metastasis (Metastasis) 04/2024 - 08/2006
37	Infections 02/2024 - 10/2009
28	Lung Neoplasms (Lung Cancer) 02/2024 - 07/2007
26	Esophageal Squamous Cell Carcinoma 03/2024 - 01/2009
25	Inflammation (Inflammations) 05/2024 - 10/2016
25	Adenocarcinoma of Lung 01/2023 - 11/2007
24	Carcinoma (Carcinomatosis) 11/2023 - 01/2003
19	Esophageal Neoplasms (Esophageal Cancer) 02/2024 - 11/2005
18	Glioma (Gliomas) 11/2021 - 12/2007
16	Breast Neoplasms (Breast Cancer) 10/2022 - 01/2002
15	COVID-19 01/2024 - 01/2020
14	Pneumonia (Pneumonitis) 11/2023 - 01/2017
12	Tuberculosis (Tuberculoses) 11/2023 - 11/2009
11	Carcinogenesis 01/2024 - 10/2016
11	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2024 - 11/2015
11	Ovarian Neoplasms (Ovarian Cancer) 01/2023 - 10/2008
11	Stomach Neoplasms (Stomach Cancer) 01/2023 - 01/2014
10	Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis) 01/2024 - 06/2008
10	Sepsis (Septicemia) 01/2024 - 10/2020
9	Disease Progression 02/2024 - 09/2011
9	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2023 - 11/2004
8	Adenocarcinoma 01/2023 - 08/2010
8	Melanoma (Melanoma, Malignant) 01/2022 - 01/2014
8	Hemorrhagic Shock 01/2020 - 01/2011
7	Wounds and Injuries (Trauma) 04/2024 - 08/2010
7	Hemorrhage 11/2023 - 01/2013
7	Lymphatic Metastasis 09/2023 - 02/2010
7	Shock 07/2019 - 02/2011
6	Hypoxia (Hypoxemia) 10/2023 - 01/2008
6	Triple Negative Breast Neoplasms 10/2023 - 01/2019
6	Hepatocellular Carcinoma (Hepatoma) 01/2023 - 01/2019
6	Brain Neoplasms (Brain Tumor) 01/2023 - 12/2007
6	Pathologic Constriction (Stenosis) 01/2017 - 01/2003
5	Asthma (Bronchial Asthma) 10/2023 - 10/2015
5	Bacterial Infections (Bacterial Infection) 08/2023 - 05/2011
5	Pain (Aches) 02/2023 - 01/2017
5	Alzheimer Disease (Alzheimer's Disease) 12/2022 - 04/2012
5	Chronic Obstructive Pulmonary Disease (COPD) 01/2022 - 10/2011
5	Parkinson Disease (Parkinson's Disease) 11/2021 - 04/2010
5	Glioblastoma (Glioblastoma Multiforme) 01/2021 - 01/2015

Drug/Important Bio-Agent (IBA)

48	Proteins (Proteins, Gene)FDA Link 02/2024 - 01/2002
40	Immune Checkpoint InhibitorsIBA 02/2024 - 01/2017
40	Biomarkers (Surrogate Marker)IBA 02/2024 - 09/2011
20	Messenger RNA (mRNA)IBA 05/2024 - 06/2005
20	MicroRNAs (MicroRNA)IBA 04/2024 - 06/2011
15	Long Noncoding RNAIBA 02/2024 - 08/2015
13	Reactive Oxygen Species (Oxygen Radicals)IBA 03/2024 - 01/2016
13	RNA (Ribonucleic Acid)IBA 01/2024 - 01/2017
12	Therapeutic UsesIBA 03/2024 - 12/2007
12	CytokinesIBA 11/2023 - 10/2009
12	AntigensIBA 09/2023 - 12/2005
12	Cisplatin (Platino)FDA LinkGeneric 01/2023 - 03/2006
11	Indicators and Reagents (Reagents)IBA 02/2024 - 11/2007
11	ErbB Receptors (EGF Receptor)IBA 11/2023 - 09/2011
11	CateninsIBA 01/2023 - 11/2010
9	Doxorubicin (Adriamycin)FDA LinkGeneric 11/2023 - 01/2002
9	Oxygen (Dioxygen)IBA 10/2023 - 02/2014
9	VaccinesIBA 09/2023 - 01/2019
9	Peptides (Polypeptides)IBA 01/2023 - 03/2014
8	AntibodiesIBA 09/2023 - 05/2009
8	Tyrosine Kinase InhibitorsIBA 07/2023 - 01/2014
7	LipidsIBA 11/2023 - 01/2021
7	PlatinumIBA 12/2020 - 10/2006
6	LipopolysaccharidesIBA 05/2024 - 01/2018
6	1- (5- (2- fluorophenyl)- 1- (pyridin- 3- ylsulfonyl)- 1H- pyrrol- 3- yl)- N- methylmethanamineIBA 02/2024 - 01/2017
6	Glucose (Dextrose)FDA LinkGeneric 02/2024 - 01/2023
6	Antiviral Agents (Antivirals)IBA 12/2023 - 01/2018
6	Chimeric Antigen ReceptorsIBA 07/2023 - 01/2015
6	AlbuminsIBA 04/2023 - 03/2018
6	AntioxidantsIBA 03/2023 - 01/2016
6	pembrolizumabIBA 02/2023 - 01/2017
6	Bevacizumab (Avastin)FDA Link 01/2022 - 01/2014
6	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 08/2010
6	Small Interfering RNA (siRNA)IBA 10/2021 - 01/2013
5	Circular RNAIBA 04/2024 - 01/2020
5	Amoxicillin (Wymox)FDA LinkGeneric 02/2024 - 01/2022
5	EnzymesIBA 02/2024 - 01/2016
5	FlavonoidsIBA 01/2024 - 01/2022
5	130-nm albumin-bound paclitaxelIBA 04/2023 - 08/2015
5	LigandsIBA 12/2022 - 09/2011
5	fibrin fragment D (D-dimer)IBA 10/2022 - 07/2016
5	Programmed Cell Death 1 ReceptorIBA 01/2022 - 01/2020
5	Immunoglobulin G (IgG)IBA 01/2021 - 12/2010
5	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021 - 03/2009
5	Pemetrexed (MTA)FDA Link 01/2021 - 05/2010
5	Monoclonal AntibodiesIBA 12/2020 - 02/2012

Therapy/Procedure

117	Therapeutics 05/2024 - 01/2003
67	Drug Therapy (Chemotherapy) 02/2024 - 01/2003
35	Immunotherapy 02/2024 - 10/2013
19	Esophagectomy 01/2024 - 01/2006
14	Radiotherapy 03/2024 - 01/2003
9	Neoadjuvant Therapy 12/2023 - 11/2004
7	Stents 11/2023 - 01/2006
7	Aftercare (After-Treatment) 10/2023 - 10/2011
6	Length of Stay 10/2023 - 01/2019
6	Precision Medicine 01/2023 - 01/2017
5	Lymph Node Excision (Lymph Node Dissection) 02/2024 - 08/2010
5	Lasers (Laser) 02/2023 - 04/2015